BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/7/2021 9:15:56 AM | Browse: 582 | Download: 1363
 |
Received |
|
2021-01-14 05:55 |
|
Peer-Review Started |
|
2021-01-14 05:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-14 06:36 |
|
Revised |
|
2021-03-04 10:11 |
|
Second Decision |
|
2021-04-20 13:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-22 04:42 |
|
Articles in Press |
|
2021-04-22 04:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-28 01:24 |
|
Publish the Manuscript Online |
|
2021-05-07 09:15 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Molecular-targeted therapy toward precision medicine for gastrointestinal cancer: Current progress and challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tasuku Matsuoka and Masakazu Yashiro |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| KAKENHI (Grant-in-Aid for Scientific Research) |
18H02883 |
|
| Corresponding Author |
Masakazu Yashiro, MD, PhD, Associate Professor, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. m9312510@med.osaka-cu.ac.jp |
| Key Words |
Gastrointestinal cancer; Esophageal cancer; Gastric cancer; Colorectal cancer; Targeted therapy; Precision medicine |
| Core Tip |
Outcomes in metastatic gastrointestinal (GI) cancer are improving with the better understanding and use of targeted therapies. Herein, a review of the literature and recent conference presentations was conducted regarding the topic of targeted therapies for precision medicine in GI cancer. This article clarifies the current evidence for targeted therapies in GI cancer by evaluating the latest data regarding anti- epidermal growth factor receptor, human epidermal growth factor receptor 2, vascular endothelial growth factor, phosphatidylinositol-3-hydroxykinase/protein kinase B, tumor growth factor-β, mesenchymal-epithelial transition, wireless network technology, poly (ADP-ribose) polymerase, and immunotherapies. |
| Publish Date |
2021-05-07 09:15 |
| Citation |
Matsuoka T, Yashiro M. Molecular-targeted therapy toward precision medicine for gastrointestinal caner: Current progress and challenges. World J Gastrointest Oncol 2021; 13(5): 366-390 |
| URL |
https://www.wjgnet.com/1948-5204/full/v13/i5/366.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v13.i5.366 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
